Today, I am excited to share the first major deliverable from our White House Initiative on Women’s Health Research: $100 million in funding for women's health research and development as part of ARPA-H's first-ever Sprint for Women’s Health. Together, we will build a new

Wow the FDA has been on a roll

Congrats Benyam Muluneh, PharmD, BCOP, FHOPA on #FHOPA! #Hopa2024

FHOPA recognitions at #HOPA2024 featured a rockstar lineup of #pharmacytarheels. Congratulations to Benyam Muluneh, PharmD, BCOP, FHOPA @lindseyamerine and @lwbpharmd on a well deserved recognition!!!!

Back by popular demand - the only thing better than #HOPA2024 is #HOPA2024 with puppies! Come and say hello, and maybe have a cuddle with them, at 5PM in the Exhibit Hall at Booth 721

Great work!!!! I can't wait to review the posters online!

Excited to see this in print! An #oncopharm collaboration between 4 centers 👏 With so many new #celltherapy & #genetherapy approvals, centers have to remain agile & develop sustainable methods but it must be done thoughtfully and w/the multidisciplinary care team. IACH

Can someone tell me who thought it was a good idea to zoom in on every gymnast's feet these Olympic games? Can you also tell me WHY? #Paris2024

👉👉👉Congratulations 🎉 to our own Leukemia PharmD * Dr Adam DiPippo * PharmD for winning 🏅 Clinical Pharmacist of The Year 2024 Award MD Anderson Cancer Center !!! #PharmD #endcancer #leusm Hagop Kantarjian,MD Gautam Borthakur Kayleigh Marx, PharmD, BCOP Tapan Kadia Naveen Pemmaraju, MD Alison Gulbis 😷💉✌🏼

Your Voice Matters. Your Vote Matters. Board Elections are now open through December 2 - find out more about the candidates, and how to cast your ballot, at the HOPA Election Center: bit.ly/3Mmrkqa

BIG WIN! 🏆 A recent bibliometric analysis published in CPTL Journal recognizes University of Kentucky College of Pharmacy as a global leader in pharmacy education research. The study ranks UKCOP as the #2 most productive institution worldwide, with 61 publications and 1,127 citations—a testament to the College’s

👉👉👉Our group’s new article led by Dr Hannah Goulart & Dr Tapan Kadia Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia AML acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… | ACS Journal Cancer MD Anderson Cancer Center #leusm #endcancer | Sanam Loghavi, MD صنم لغوی 🔬🧬

Multicenter retrospective evaluation of treatment for high risk acute promyelocytic #leukemia: Comparison of the APML4 and ATRA+ATO+GO in high risk #APL conducted by the HERO Consortium Free access: doi.org/10.1002/ajh.27… #LeuSM Bernie Marini #HemOnc

This year's #ASCO25 has been mind blowing in almost all disciplines, with multiple high-quality simultaneous publications, including in hematology! Congrats ASCO and all presenters! Here are the most impressive malignant hematology studies🧵

👉👉 Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL. We did not see any significant responses in R/R adult Ph-like B-ALL with ruxolitinib. 👉Looking back at my emails Marina Konopleva and I had initial discussions with Incyte for this trial at ASH

The Journal of Hematology Oncology Pharmacy (Journal of Hematology Oncology Pharmacy) is recruiting HOPA members to serve as manuscript reviewers. This opportunity is ideal for young professionals who are looking to gain expertise in scholarly manuscripts. Apply today: bit.ly/3JoBG7W

The 17 fired members of ACIP, including me, have written an article in JAMA about our experience and our concerns. jamanetwork.com/journals/jama/…

Amer Zeidan MBBS,MHS ‏عامر زيدان Sorry to learn, thanks for sharing. Let’s see what the subgroup analyses reveal: bridged to alloSCT vs. Not, ASXL1mut vs. Not etc.

Excited to pop over to Austin to talk shop about Heme Malignancies and ASCO updates. Hit me up if you're in town!

Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL) | Leukemia nature.com/articles/s4137…